Tracking Triple-negative Breast Cancer Evolution Through Therapy

NAActive, not recruitingINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

April 14, 2017

Primary Completion Date

June 1, 2024

Study Completion Date

May 31, 2026

Conditions
Triple-Negative Breast Neoplasm
Interventions
PROCEDURE

Biopsy

Biopsy of primary tumour to be performed prior to initiation of neoadjuvant chemotherapy

PROCEDURE

Biopsy (optional)

\[Optional\] biopsy of primary tumour to be performed after 4 weeks of neoadjuvant chemotherapy

PROCEDURE

Biopsy (metastatic)

Biopsy of metastatic site to be performed at the time of relapse

Trial Locations (10)

Unknown

Centre Jean Perrin, Clermont-Ferrand

Centre George François Leclerc, Dijon

Centre Leon Bérard, Lyon

Institut Paoli Calmettes, Marseille

Institut de Cancerologie de l'Ouest, Nantes

Centre Eugène Marquis, Rennes

Centre Paul Strauss, Strasbourg

Hopitaux universitaire de strasbourg - Hopital civil, Strasbourg

Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

Gustave Roussy, Villejuif

All Listed Sponsors
collaborator

National Cancer Institute, France

OTHER_GOV

lead

UNICANCER

OTHER

NCT03077776 - Tracking Triple-negative Breast Cancer Evolution Through Therapy | Biotech Hunter | Biotech Hunter